Low fat intake is associated with pathological manifestations and poor recovery in patients with hepatocellular carcinoma

Table 1 Summary of patients’ characteristics

Items	Group 1 (n = 35)	Group 2 (n = 20)
Age	68.5 ± 8.2	71.0 ± 8.2
Gender (male/female)	28/7	14/6
Body mass index	24.3 ± 3.2	24.6 ± 3.5
Background (HBV/HCV/Alcohol/NASH/PBC/AIH)	12/14/6/3/1/0	4/11/3/1/0/1
Child-Pugh score (5/6/7/8/9)	20/7/6/0/2	11/5/3/0/1
TNM stage (I/II/III/IV)	18/9/3/5	6/5/4/5
Treatment (RFA/TACE/TOCE/HAIC/Sorafenib/No)	8/6/3/11/1/6	4/6/3/7/0/0
BCAA supplementation (+/−)	21/14	11/9
PT-INR on admission	1.12 ± 0.09	1.09 ± 0.08

HBV hepatitis B virus, HCV hepatitis C virus, NASH nonalcoholic steatohepatitis, PBC primary biliary cirrhosis, AIH autoimmune hepatitis, TNM tumor-node-metastasis, RFA radiofrequency ablation, TACE transcatheter hepatic arterial chemoembolization, TOCE transcatheter oily chemoembolization, HAIC hepatic arterial infusion chemotherapy, BCAA branched-chain amino acids, PT-INR prothrombin time-international normalized ratio.

ISSN: 1475-2891